CooperSurgical is driven to advance the care of women, babies, and families around the world. We believe in empowering individuals and healthcare professionals in making health and life choices. We are trusted by clinicians worldwide for products, technologies, and services that support a wide range of reproductive solutions, from contraception to fertility and preventative and therapeutic gynecological care.
Nexpring Health unites industry leaders into one powerful global force, dedicated to advancing infertility care and redefining the future of ART by putting you - the embryologists, clinicians, and fertility clinics at the center of everything they do. Their solutions transform your daily reality by simplifying the complex, while their unwavering, hands-on support empowers you to achieve consistent, high-quality outcomes.
Vitrolife Group is a global leader in reproductive health, dedicated to helping people fulfil the dream of parenthood. With innovative solutions spanning fertility treatments, genetic testing, and medical device technologies, we support clinics and laboratories worldwide in achieving higher success rates. Our portfolio includes products and services for IVF, embryo culture, time-lapse monitoring, cryopreservation, and advanced genetic analysis. By combining science, technology, and passion, Vitrolife Group partners with healthcare professionals to improve patient outcomes and shape the future of assisted reproduction. Operating in more than 110 countries, we are committed to advancing fertility care with quality and trust.
For all enquiries regarding sponsorship or exhibiting at the ARCS 2025 Symposium, please contact claire.ball@profileproductions.co.uk
As part of the organisation of this conference, the University of Birmingham is collecting income via registration fees and sponsorships on behalf of the ARCS 2025 Symposium organising committee.
Accessibility Statement